Abstract
Abstract
ABSTRACT
Forty-four patients who had rheumatoid arthritis were evaluated clinically and by laboratory tests. Twenty-two
patients received zinc sulphate capsule (50 mg/day) plus standard treatment, while twenty-two patients received
placebo and standard treatment. All th1e patients were evaluated one month later. Those who received zinc therapy
revealed significant improvement in both clinical and laboratory tests, in comparison with those who received placebo
therapy.
ABSTRACT
Forty-four patients who had rheumatoid arthritis were evaluated clinically and by laboratory tests. Twenty-two
patients received zinc sulphate capsule (50 mg/day) plus standard treatment, while twenty-two patients received
placebo and standard treatment. All th1e patients were evaluated one month later. Those who received zinc therapy
revealed significant improvement in both clinical and laboratory tests, in comparison with those who received placebo
therapy.